Abstract
Some accidents due to methotrexate (MTX) have been reported to the Dutch Health Authorities. However, for modern, intensive treatment of patients with rheumatoid arthritis and various other chronic autoimmune diseases, we cannot do without the drug, because of its broad applications and unique properties. Fortunately, it is a safe drug, if used by doctors experienced in using it and who follow MTX guidelines.
Translated title of the contribution | [Methotrexate: mainstay of rheumatoid arthritis treatment]. |
---|---|
Original language | Dutch |
Journal | Nederlands Tijdschrift voor Geneeskunde |
Volume | 153 |
Publication status | Published - 1 Dec 2009 |